Oral Ibuprofene versus oral kethorolac for children with musculoskeletal injury: a double blind randomized controlled study. - IbuKet

IRCCS MATERNO INFANTILE BURLO GAROFOLO0 个研究点目标入组 250 人开始时间: 2021年2月10日最近更新: 2023年9月11日

适应症

试验速览

暂无简介。

•Inclusion Criteria: All the following requirements must be met:
•Present moderate-severe pain (value> = 4 on the NRS scale)
•Pain must be due to a trauma that has occurred in the last 48 hours
•Trauma must occur at limbs
•Age between 8 and 18 years: from the age of 8, until the completion of the eighteen years of age.
•Are the trial subjects under 18? yes
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) no
•F.1.2.1 Number of subjects for this age range
•F.1.3 Elderly (>=65 years) no
•F.1.3.1 Number of subjects for this age range

•Will be excluded from the study every patient that met at list one of the following criteria:
•Administration of any analgesic in the previous 8 hours.
•Allergy known to one of the active ingredients
•Known hepatopathy or nephropathy
•Suspicion of violence by others
•Chronic use of painkillers
•Inability to report pain due to the presence of:
•or Intellectual disability (IQ & lt; 70)
•or moderate-severe hearing loss
•Communication limitations such as patient mutism
•Unable to write.
•Inability to speak Italian
•Chronic neurological or metabolic diseases,
•Positive history for ease of bleeding, coagulation disorder or
•thrombocytopenia
•A history of gastritis or esophagitis in the last 30 days
•Multiple trauma
•Vascular-vascular deficit
•State of pregnancy

发起方

IRCCS MATERNO INFANTILE BURLO GAROFOLO